Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Sanofi describes new series acting on vasopressin and/or oxytocin receptors

Sep. 30, 1998

Selective NHE-1 inhibitor from Merck KGaA produces significant cardioprotective effects

Sep. 29, 1998

Resten-NG on track for clinical testing

Sep. 29, 1998

CV Therapeutics initiates phase I clinical trial for treatment of atrial arrhythmias

Sep. 28, 1998

Clinical results support use of nesiritide over dobutamine in acute CHF

Sep. 25, 1998

Kissei discovers series of vascular smooth muscle cell proliferation inhibitors

Sep. 25, 1998

CV Therapeutics, Incyte collaborate on cardiovascular gene research

Sep. 23, 1998

Japanese market introduction announced for angiotensin II blocker

Sep. 23, 1998

New NOS inhibitors prepared at Ono described in patent literature

Sep. 22, 1998

New cardioprotectant from RPR shows potential in treating acute myocardial infarction

Sep. 21, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...